Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
uniQure Inc.
uniQure Announces Pricing of Upsized $225 Million Public Offering
June 23, 2026
uniQure Announces $150 Million Proposed Public Offering
June 22, 2026
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
June 19, 2026
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
June 17, 2026
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
May 8, 2026
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease
May 8, 2026
uniQure to Announce First Quarter 2026 Financial Results
May 7, 2026
uniQure Announces 2025 Financial Results and Provides Recent Company Updates
April 29, 2026
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
April 29, 2026
uniQure to Announce 2025 Financial Results
April 28, 2026
1
2
Next Page
→